BMCM
VRTX icon

Bryn Mawr Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bryn Mawr Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$368K Buy
826
+370
+81% +$165K 0.02% 314
2025
Q1 		$221K Buy
+456
New +$221K 0.01% 363